PRIMARY MALIGNANCY of the fallopian tube is rare, constituting only 0.13% to 1.17% of all gynecologic malignancies.(1) It usually occurs in postmenopausal women. The major predictor of survival for patients with fallopian tube cancer is the stage of the disease at the time of diagnosis. Several series have reported a 5-year survival of 0% to 29% in stage III and O% to 10% in stage IV disease. It has been suggested that this poor prognosis is often due to late diagnosis, rather than the intrinsic malignant nature of the tumor.(1-3)